Off-label 'miracle' weight loss worry

Posted 10 May AM

A rush on Novo Nordisk's diabetes drug Ozempic for off label use as a 'miracle' weight loss drug has resulted in a squeeze on local supply of the medicine.

The company has confirmed there may be 'intermittent availability' of Ozempic after a report in The Australian newspaper revealed thousands of Australians had started using the drug to shed kilos, with the once-a-week injectable helping to supress hunger.

To see the whole article please log in.

Log in with your member email for full access.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

Email

Retype password

Not a member? Sign up here